Fipexide: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})
 
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Protected "Fipexide": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{drugbox
{{Drugbox
| IUPAC_name       = 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-<br>2-(4-chlorophenoxy)ethanone
| verifiedrevid = 443216648
| image             = Fipexide.png
| IUPAC_name = 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-<br>2-(4-chlorophenoxy)ethanone
| CAS_number        = 34161-24-5
| image = Fipexide.png
| ATC_prefix        = N06
 
| ATC_suffix        = BX05
<!--Clinical data-->
| PubChem          = 3351
| tradename =   
| DrugBank          =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| C = 20 | H = 21 | Cl = 1 | N = 2 | O = 4
| pregnancy_US = <!-- A / B            / C / D / X -->
| molecular_weight = 388.845 g/mol
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| bioavailability  =
| legal_CA = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| protein_bound    =
| legal_UK = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| metabolism        =
| legal_US = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| elimination_half-life =
 
| excretion        =
<!--Identifiers-->
| pregnancy_AU     = <!-- A / B1 / B2 / B3 / C / D / X -->
| CAS_number_Ref = {{cascite|correct|??}}
| pregnancy_US     = <!-- A / B            / C / D / X -->
| CAS_number = 34161-24-5
| pregnancy_category= 
| ATC_prefix = N06
| legal_AU         = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| ATC_suffix = BX05
| legal_CA         = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| PubChem = 3351
| legal_UK         = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| legal_US         = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| legal_status      =  
| ChemSpiderID = 3234
| routes_of_administration =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TG44VME01D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07345
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 254857
 
<!--Chemical data-->
| C=20 | H=21 | Cl=1 | N=2 | O=4
| molecular_weight = 388.845 g/mol
| smiles = Clc4ccc(OCC(=O)N1CCN(CC1)Cc2ccc3OCOc3c2)cc4
| InChI = 1/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2
| InChIKey = BFUJHVVEMMWLHC-UHFFFAOYAN
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BFUJHVVEMMWLHC-UHFFFAOYSA-N
}}
}}
'''Fipexide''' is a [[piperazine]] derivative drug invented in Italy in 1983.<ref> Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85. </ref>  
              __NOTOC__
{{SI}}
{{CMG}}
==Overview==
   
'''Fipexide''' ('''Attentil''', '''Vigilor''') is a [[psychoactive drug]] of the [[piperazine]] [[chemical class]] which was developed in [[Italy]] in 1983.<ref>Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.</ref> It was used as a [[nootropic]] drug in Italy and [[France]], mainly for the treatment of senile dementia,<ref>Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.</ref> but is no longer in common use due to the occurrence of rare adverse drug reactions including [[fever]]<ref>Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.</ref> and [[hepatitis]]. Fipexide is similar in action to other nootropic drugs such as [[piracetam]] and is structurally similar to another more well-known nootropic, [[centrophenoxine]]. Chemically, it is an amide union of [[parachlorophenoxyacetate]] and [[methylenedioxybenzylpiperazine]] (MDBZP), and has been shown to metabolize to the latter, which plays a significant role in its effects.
 
==See also==
* [[Befuraline]]
 
 
==References==
{{Reflist|2}}
 


It was used as a [[nootropic]] drug in France and Italy, mainly for the treatment of senile dementia,<ref> Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106. </ref> but is no longer in common use due to the occurrence of rare adverse drug reactions including [[fever]]<ref> Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31. </ref> and [[hepatitis]]. Fipexide is similar in action to other nootropic drugs such as [[piracetam]] and is structurally similar to another more well-known nootropic, [[centrophenoxine]].
{{Nootropics}}


== References ==
{{reflist|2}}


{{Psychostimulants, agents used for ADHD and nootropics}}
[[Category:Nootropics]]
[[Category:Nootropics]]
{{WikiDoc Sources}}
 
[[Category:Piperazines]]
[[Category:Amides]]
[[Category:Phenol ethers]]
[[Category:Organochlorides]]
[[Category:Drug]]

Latest revision as of 20:57, 18 August 2015

Fipexide
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H21ClN2O4
Molar mass388.845 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Fipexide

Articles

Most recent articles on Fipexide

Most cited articles on Fipexide

Review articles on Fipexide

Articles on Fipexide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fipexide

Images of Fipexide

Photos of Fipexide

Podcasts & MP3s on Fipexide

Videos on Fipexide

Evidence Based Medicine

Cochrane Collaboration on Fipexide

Bandolier on Fipexide

TRIP on Fipexide

Clinical Trials

Ongoing Trials on Fipexide at Clinical Trials.gov

Trial results on Fipexide

Clinical Trials on Fipexide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fipexide

NICE Guidance on Fipexide

NHS PRODIGY Guidance

FDA on Fipexide

CDC on Fipexide

Books

Books on Fipexide

News

Fipexide in the news

Be alerted to news on Fipexide

News trends on Fipexide

Commentary

Blogs on Fipexide

Definitions

Definitions of Fipexide

Patient Resources / Community

Patient resources on Fipexide

Discussion groups on Fipexide

Patient Handouts on Fipexide

Directions to Hospitals Treating Fipexide

Risk calculators and risk factors for Fipexide

Healthcare Provider Resources

Symptoms of Fipexide

Causes & Risk Factors for Fipexide

Diagnostic studies for Fipexide

Treatment of Fipexide

Continuing Medical Education (CME)

CME Programs on Fipexide

International

Fipexide en Espanol

Fipexide en Francais

Business

Fipexide in the Marketplace

Patents on Fipexide

Experimental / Informatics

List of terms related to Fipexide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Fipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983.[1] It was used as a nootropic drug in Italy and France, mainly for the treatment of senile dementia,[2] but is no longer in common use due to the occurrence of rare adverse drug reactions including fever[3] and hepatitis. Fipexide is similar in action to other nootropic drugs such as piracetam and is structurally similar to another more well-known nootropic, centrophenoxine. Chemically, it is an amide union of parachlorophenoxyacetate and methylenedioxybenzylpiperazine (MDBZP), and has been shown to metabolize to the latter, which plays a significant role in its effects.

See also


References

  1. ↑ Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.
  2. ↑ Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.
  3. ↑ Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.


Template:Nootropics

Retrieved from "https://www.wikidoc.org/index.php?title=Fipexide&oldid=1135361"